Wealth Enhancement Advisory Services LLC grew its position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 32.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 27,563 shares of the medical research company's stock after acquiring an additional 6,828 shares during the quarter. Wealth Enhancement Advisory Services LLC's holdings in Agilent Technologies were worth $3,703,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds have also recently bought and sold shares of A. Sienna Gestion boosted its holdings in shares of Agilent Technologies by 29.8% in the 4th quarter. Sienna Gestion now owns 78,445 shares of the medical research company's stock worth $10,537,000 after buying an additional 17,991 shares during the last quarter. Sequoia Financial Advisors LLC boosted its holdings in shares of Agilent Technologies by 8.5% in the 4th quarter. Sequoia Financial Advisors LLC now owns 33,898 shares of the medical research company's stock worth $4,554,000 after buying an additional 2,664 shares during the last quarter. Prudential PLC boosted its holdings in shares of Agilent Technologies by 16.0% in the 4th quarter. Prudential PLC now owns 73,273 shares of the medical research company's stock worth $9,843,000 after buying an additional 10,128 shares during the last quarter. Commonwealth Equity Services LLC boosted its holdings in shares of Agilent Technologies by 9.8% in the 4th quarter. Commonwealth Equity Services LLC now owns 43,862 shares of the medical research company's stock worth $5,892,000 after buying an additional 3,915 shares during the last quarter. Finally, Daiwa Securities Group Inc. boosted its holdings in shares of Agilent Technologies by 16.0% in the 4th quarter. Daiwa Securities Group Inc. now owns 49,288 shares of the medical research company's stock worth $6,621,000 after buying an additional 6,802 shares during the last quarter.
Wall Street Analyst Weigh In
Several research firms have commented on A. Robert W. Baird dropped their price objective on shares of Agilent Technologies from $159.00 to $140.00 and set an "outperform" rating on the stock in a report on Thursday, May 22nd. JPMorgan Chase & Co. decreased their price target on Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating on the stock in a research report on Thursday, May 29th. TD Cowen upped their price target on Agilent Technologies to $150.00 and gave the company a "buy" rating in a research report on Thursday, May 29th. Wells Fargo & Company decreased their price target on Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating on the stock in a research report on Thursday, April 17th. Finally, Jefferies Financial Group decreased their price target on Agilent Technologies from $135.00 to $116.00 and set a "hold" rating on the stock in a research report on Monday, April 21st. Seven equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to MarketBeat, Agilent Technologies currently has an average rating of "Moderate Buy" and an average target price of $140.15.
Read Our Latest Report on Agilent Technologies
Agilent Technologies Trading Up 1.7%
A stock traded up $1.96 on Friday, reaching $115.90. The company's stock had a trading volume of 1,556,432 shares, compared to its average volume of 1,913,545. The business has a fifty day simple moving average of $108.10 and a two-hundred day simple moving average of $125.95. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $153.84. The firm has a market cap of $32.92 billion, a PE ratio of 28.62, a PEG ratio of 3.46 and a beta of 1.23. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.60 and a current ratio of 2.09.
Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings data on Wednesday, May 28th. The medical research company reported $1.31 EPS for the quarter, beating the consensus estimate of $1.26 by $0.05. The business had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.63 billion. Agilent Technologies had a return on equity of 25.92% and a net margin of 17.59%. The company's revenue for the quarter was up 6.0% on a year-over-year basis. During the same quarter last year, the firm posted $1.22 earnings per share. As a group, research analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current year.
Agilent Technologies Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 23rd. Stockholders of record on Tuesday, July 1st will be issued a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $0.99 annualized dividend and a dividend yield of 0.86%. Agilent Technologies's payout ratio is presently 24.44%.
Insider Activity
In related news, Director Daniel K. Podolsky sold 1,819 shares of Agilent Technologies stock in a transaction dated Monday, March 31st. The stock was sold at an average price of $116.46, for a total value of $211,840.74. Following the completion of the sale, the director now directly owns 35,737 shares in the company, valued at approximately $4,161,931.02. This trade represents a 4.84% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Rodney Gonsalves sold 1,908 shares of Agilent Technologies stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $121.98, for a total value of $232,737.84. Following the completion of the sale, the vice president now owns 21,786 shares of the company's stock, valued at $2,657,456.28. The trade was a 8.05% decrease in their ownership of the stock. The disclosure for this sale can be found here.
About Agilent Technologies
(
Free Report)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Read More
Before you consider Agilent Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.
While Agilent Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
